An Immunological Hub of Excellence in Porto tailored to fulfil the ERA Priorities

Informations projet

ImmunoHUB

N° de convention de subvention: 951921

DOI 10.3030/951921

Date de signature de la CE 10 Juin 2020

Date de début 1 Janvier 2021

Date de fin 31 Decembre 2026

Financé au titre de

• Establishing ‚ERA Chairs’

Coût total € 2 475 826,25

Contribution de l’UE € 2 475 826,25

Coordonné par

INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
Portugal

Livrables

Websites, patent fillings, videos etc. (3)

Implementation of the ImmunoHUB seminar series and Annual Meeting
Communication Toolkit
Public Website

Documents, reports (1)

Report on the recruitment of the ERA Chair holder

Open Research Data Pilot (1)

Data Management Plan

Publications

Peer reviewed articles (5)

Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells

Auteurs: Natalija Jonić, Ivan Koprivica, Christos M. Chatzigiannis, Antonis D. Tsiailanis, Stavroula G. Kyrkou, Eleftherios Paraskevas Tzakos, Aleksandar Pavić, Mirjana Dimitrijević, Andjelina Jovanović, Milan B. Jovanović, Sérgio Marinho, Inês Castro-Almeida, Vesna Otašević, Pedro Moura-Alves, Andreas G. Tzakos, Ivana Stojanović
Publié dans: Molecules, Numéro 29, 2024, Page(s) 2988, ISSN 1420-3049
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/molecules29132988

Single-cell profiling of MC1R-inhibited melanocytes

Auteurs: H. Matthew Berns, Dawn E. Watkins-Chow, Sizhu Lu, Pakavarin Louphrasitthiphol, Tongwu Zhang, Kevin M. Brown, Pedro Moura-Alves, Colin R. Goding, William J. Pavan
Publié dans: Pigment Cell & Melanoma, Numéro 37, 2024, Page(s) 291-308, ISSN 1755-1471
Éditeur: Basil Blackwell
DOI: 10.1111/pcmr.13141

The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation

Auteurs: Jana Flegel, Saad Shaaban, Zhi Jun Jia, Britta Schulte, Yilong Lian, Adrian Krzyzanowski, Malte Metz, Tabea Schneidewind, Fabian Wesseler, Anke Flegel, Alisa Reich, Alexandra Brause, Gang Xue, Minghao Zhang, Lara Dötsch, Isabelle D. Stender, Jan-Erik Hoffmann, Rebecca Scheel, Petra Janning, Fraydoon Rastinejad, Dennis Schade, Carsten Strohmann, Andrey P. Antonchick, Sonja Sievers, Pedro Moura-Alv
Publié dans: Journal of Medicinal Chemistry, Numéro 65, 2022, Page(s) 16268–16289, ISSN 0022-2623
Éditeur: American Chemical Society
DOI: 10.1021/acs.jmedchem.2c00956

Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study

Auteurs: Mankgopo Kgatle, Joseph Musonda Chalwe, Donald van der Westhuizen, Shuting Xu, Botle Precious Damane, Precious Mathebela, Veronica Ueckermann, Simnikiwe Mayaphi, Hosana Gomes Rodrigues, Pedro Moura-Alves, Honest Ndlovu, Yonwaba Mzizi, Lusanda Zongo, Henry Hairwadzi, Mariza Vorster, Jan Rijn Zeevaart, Mike Sathekge
Publié dans: COVID, Numéro 3, 2023, Page(s) 999-1010, ISSN 2673-8112
Éditeur: MDPI
DOI: 10.3390/covid3070072

Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation

Auteurs: Catarina J.G. Pinto, María Ángeles Ávila-Gálvez, Yilong Lian, Pedro Moura-Alves, Cláudia Nunes dos Santos
Publié dans: Redox Biology, Numéro 61, 2023, ISSN 2213-2317
Éditeur: Elsevier BV
DOI: 10.1016/j.redox.2023.102622